Table 1 Patient Characteristics: European descent (n = 89)

Age (years)

57 ± 13.5

Age at diagnosis (years)

47 ± 15

Women: (%)

75

Disease duration (years)

8 ±8

Current Smokers (%)

15

Pain VAS

50.0 ± 22.3

Health VAS

46.4 ± 17.5

Tender (no.)

11.8 ± 6.2

Swollen (no.)

11.2 ± 4.8

HAQ

1.13 ± 0.61

Physician’s global assessment

49.4 ± 19.0

RF at baseline

238.2 ± 369.6

RF+ %

83.75%^a

Serum CRP level (md/dl) at baseline

1.7 ± 2.0

CCP+ %

61.9%^b

DAS 28 at baseline

5.22 ± 0.80

DAS 28 at 6 wk

3.99 ± 1.13

DAS 28 at 14 wk

3.72 ± 1.32

anti-TNF drug

Enbrel

n = 39

Humira

n = 18

Remicade

n = 32

Other Medication

Steroids

63%

Methotrexate

63%

DMARDS

46%

Arava

n = 16

Azathioprine

n = 1

Sulfasalazine

n = 18

Plaquenil

n = 15